Hot Controversies, but No Hot-Line Sizzlers

EASD 2011 — LISBON — Though there's "no major endpoint trial" being presented at this year's European Association for the Study of Diabetes meeting here, executive director Viktor Joergens, MD, said there will be plenty of debate over several recent controversies.


< Back to Listings